Cipla, has approached the Drug Controller General of India to get a green signal to use the 'Moderna' Covid vaccine for emergency use in India.
Cipla, Moderna Covid vaccine
To speed up vaccination in India: Cipla gets nod to import Moderna's Covid vaccine for emergency use
Cipla, The leading pharmaceutical company, has approached the Drug Controller General of India for a green signal to use the 'Moderna' Covid vaccine for emergency use in the country. Cipla distributes Moderna's Covid-19 vaccine in India
On Monday, Mumbai-based pharmaceutical company Cipla approached the Drug Controller seeking permission to import the Moderna vaccine.
Moderna is said to be 90 percent effective against Covid: Moderna vaccine, which is 90% resistant against Covid-19, is widely accepted in many parts of the world.
